{"nct_id":"NCT03412565","title":"A Study to Evaluate Subcutaneous Daratumumab in Combination With Standard Multiple Myeloma Treatment Regimens","status":"COMPLETED","status_verified_date":"2025-04","start_date":"2018-04-26","start_date_type":"ACTUAL","primary_completion_date":"2020-08-12","primary_completion_date_type":"ACTUAL","completion_date":"2024-04-18","completion_date_type":"ACTUAL","phases":["PHASE2"],"tickers":["JNJ"]}